{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:27:24Z","timestamp":1791502044574,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jbc.2025.110595","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T06:40:11Z","timestamp":1755067211000},"page":"110595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Potent antioxidant and mitochondrial-protective effects of ATH434, a moderate affinity iron chaperone"],"prefix":"10.1016","volume":"301","author":[{"given":"Danielle K.","family":"Bailey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhudwan","family":"Nihlawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1998-5634","authenticated-orcid":false,"given":"Margaret J.","family":"Bradbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silas","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Kosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110595_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/jnnp.60.1.98","article-title":"Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy","volume":"60","author":"Schwarz","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiat."},{"key":"10.1016\/j.jbc.2025.110595_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuroimage.2010.11.073","article-title":"Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease","volume":"55","author":"Leskovjan","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.jbc.2025.110595_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-130209","article-title":"Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging","volume":"37","author":"Raven","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jbc.2025.110595_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fphar.2014.00081","article-title":"The iron regulatory capability of the major protein participants in prevalent neurodegenerative disorders","volume":"5","author":"Wong","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2025.110595_bib5","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1021\/ic201233b","article-title":"Iron(II) binding to amyloid-beta, the Alzheimer's peptide","volume":"50","author":"Bousejra-ElGarah","year":"2011","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1006\/bbrc.1995.2678","article-title":"The role of iron in beta amyloid toxicity","volume":"216","author":"Schubert","year":"1995","journal-title":"Biochem. Biophysical Res. Commun."},{"key":"10.1016\/j.jbc.2025.110595_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0891-5849(00)00494-9","article-title":"Redox-active iron mediates amyloid-\u03b2 toxicity","volume":"30","author":"Rottkamp","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jbc.2025.110595_bib8","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000","article-title":"The A53T \u03b1-synuclein mutation increases iron-dependent aggregation and toxicity","volume":"20","author":"Ostrerova-Golts","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jbc.2025.110595_bib9","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1074\/jbc.M110.158980","article-title":"Iron promotes the toxicity of amyloid \u03b2 peptide by impeding its ordered aggregation","volume":"286","author":"Liu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1089\/ars.2015.6343","article-title":"Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease","volume":"24","author":"Deas","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jbc.2025.110595_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1471-4159.2000.0740270.x","article-title":"In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer\u2019s disease: a central role for bound transition metals","volume":"74","author":"Sayre","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jbc.2025.110595_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbadis.2016.01.002","article-title":"Differential interaction between iron and mutant alpha-synuclein causes distinctive Parkinsonian phenotypes in Drosophila","volume":"1862","author":"Zhu","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2025.110595_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00401-007-0220-y","article-title":"The dentate nucleus in Friedreich's ataxia: the role of iron-responsive proteins","volume":"114","author":"Koeppen","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jbc.2025.110595_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/mds.27606","article-title":"Longitudinal evaluation of iron concentration and atrophy in the dentate nuclei in friedreich ataxia","volume":"34","author":"Ward","year":"2019","journal-title":"Mov Disord."},{"key":"10.1016\/j.jbc.2025.110595_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/archneur.56.5.569","article-title":"Increased basal ganglia iron levels in Huntington disease","volume":"56","author":"Bartzokis","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jbc.2025.110595_bib16","first-page":"275","article-title":"MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease","volume":"14","author":"Chen","year":"1993","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jbc.2025.110595_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0020-1693(00)82997-7","article-title":"Stabilities of the iron(III) chelates of 1,2-dimethyl-3-hydroxy-4-pyridinone and related ligands","volume":"183","author":"Motekaitis","year":"1991","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jbc.2025.110595_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfae044","article-title":"ATH434, a promising iron-targeting compound for treating iron regulation disorders","volume":"16","author":"Pall","year":"2024","journal-title":"Metallomics"},{"key":"10.1016\/j.jbc.2025.110595_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1134\/S1070363215040337","article-title":"Complexation modulated redox behavior of transition metal systems (review)","volume":"85","author":"Rizvi","year":"2015","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib20","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1038\/s41598-019-39214-1","article-title":"Deferiprone: pan-selective histone lysine demethylase inhibition activity and structure activity relationship study","volume":"9","author":"Khodaverdian","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.110595_bib21","first-page":"1","article-title":"Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential","volume":"6","author":"Labb\u00e9","year":"2013","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.jbc.2025.110595_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaneurol.2024.3733","article-title":"Deferiprone in alzheimer disease: a randomized clinical trial","volume":"82","author":"Ayton","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jbc.2025.110595_bib23","series-title":"European Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial of Deferiprone","article-title":"Conservative iron chelation as a disease-modifying strategy in Parkinson's disease","year":"2016"},{"key":"10.1016\/j.jbc.2025.110595_bib24","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","article-title":"Trial of deferiprone in Parkinson's disease","volume":"387","author":"Devos","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.110595_bib25","series-title":"Encyclopedia of Inorganic and Bioinorganic Chemistry","article-title":"Iron Proteins with Mononuclear Active Sites","author":"Emerson","year":"2011"},{"key":"10.1016\/j.jbc.2025.110595_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2377-8-20","article-title":"Deferiprone targets aconitase: implication for Friedreich's ataxia treatment","volume":"8","author":"Goncalves","year":"2008","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jbc.2025.110595_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1517\/17425255.2012.640674","article-title":"Deferasirox: pharmacokinetics and clinical experience","volume":"8","author":"Galanello","year":"2012","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jbc.2025.110595_bib28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1586\/erp.09.26","article-title":"Pharmacoeconomic benefits of deferasirox in the management of iron overload syndromes","volume":"9","author":"Imran","year":"2009","journal-title":"Expert Rev. Pharmacoecon Outcomes Res."},{"key":"10.1016\/j.jbc.2025.110595_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000243801","article-title":"Deferasirox (Exjade) for the treatment of iron overload","volume":"122","author":"Cappellini","year":"2009","journal-title":"Acta Haematol."},{"key":"10.1016\/j.jbc.2025.110595_bib30","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/biom12030365","article-title":"Effects of deferasirox in Alzheimer's disease and Tauopathy animal models","volume":"12","author":"Kwan","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jbc.2025.110595_bib31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-150514","article-title":"The oral iron chelator, deferasirox, reverses the age-dependent alterations in iron and amyloid-beta homeostasis in rat brain: implications in the therapy of alzheimer's disease","volume":"49","author":"Banerjee","year":"2016","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jbc.2025.110595_bib32","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2010.04.011","article-title":"Electrode potentials of partially reduced oxygen species, from dioxygen to water","volume":"49","author":"Koppenol","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jbc.2025.110595_bib33","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1021\/jf049243r","article-title":"Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration","volume":"52","author":"Heo","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib34","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.3390\/molecules23123305","article-title":"Overview on the effects of N-acetylcysteine in neurodegenerative diseases","volume":"23","author":"Tardiolo","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2025.110595_bib35","doi-asserted-by":"crossref","first-page":"28194","DOI":"10.3390\/ijms161226095","article-title":"Old things New view: ascorbic acid protects the brain in neurodegenerative disorders","volume":"16","author":"Covarrubias-Pinto","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2025.110595_bib36","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ahj.2010.10.038","article-title":"Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA)","volume":"161","author":"Lagedrost","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.jbc.2025.110595_bib37","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archneurol.2010.168","article-title":"A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxia","volume":"67","author":"Lynch","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jbc.2025.110595_bib38","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1468-1331.2008.02318.x","article-title":"Coenzyme Q10 and vitamin E deficiency in Friedreich's ataxia: predictor of efficacy of vitamin E and coenzyme Q10 therapy","volume":"15","author":"Cooper","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jbc.2025.110595_bib39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jnc.12322","article-title":"Co-enzyme Q10 and idebenone use in Friedreich's ataxia","volume":"126","author":"Parkinson","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jbc.2025.110595_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12311-010-0212-7","article-title":"Combined therapy with idebenone and deferiprone in patients with Friedreich's ataxia","volume":"10","author":"Velasco-S\u00e1nchez","year":"2011","journal-title":"Cerebellum"},{"key":"10.1016\/j.jbc.2025.110595_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1364261","article-title":"Deferiprone-resveratrol hybrid attenuates iron accumulation, oxidative stress, and antioxidant defenses in iron-loaded human Huh7 hepatic cells","volume":"11","author":"Li","year":"2024","journal-title":"Front Mol. Biosci."},{"key":"10.1016\/j.jbc.2025.110595_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3233\/JPD-212877","article-title":"The compound ATH434 prevents alpha-synuclein toxicity in a murine model of multiple system atrophy","volume":"12","author":"Finkelstein","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jbc.2025.110595_bib43","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/mds.28714","article-title":"ATH434 reduces alpha-synuclein-related neurodegeneration in a murine model of multiple system atrophy","volume":"36","author":"Heras-Garvin","year":"2021","journal-title":"Mov Disord."},{"key":"10.1016\/j.jbc.2025.110595_bib44","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40478-017-0456-2","article-title":"The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease","volume":"5","author":"Finkelstein","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jbc.2025.110595_bib45","article-title":"Management versus miscues in the cytosolic labile iron pool: the varied functions of iron chaperones","volume":"1867","author":"Philpott","year":"2020","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jbc.2025.110595_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254794","article-title":"The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells","volume":"16","author":"Bailey","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2025.110595_bib48","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/cdd.2010.92","article-title":"Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons","volume":"18","author":"Tobaben","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2025.110595_bib49","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1111\/j.1471-4159.2007.04884.x","article-title":"Necrostatin-1 protects against glutamate-induced glutathione depletion and caspase-independent cell death in HT-22 cells","volume":"103","author":"Xu","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jbc.2025.110595_bib50","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1083\/jcb.141.6.1423","article-title":"The regulation of reactive oxygen species production during programmed cell death","volume":"141","author":"Tan","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110595_bib51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1179\/1743132811Y.0000000057","article-title":"Differentiation of HT22 neurons induces expression of NMDA receptor that mediates homocysteine cytotoxicity","volume":"34","author":"Zhao","year":"2012","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jbc.2025.110595_bib52","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.4103\/1673-5374.121636","article-title":"Differentiation renders susceptibility to excitotoxicity in HT22 neurons","volume":"8","author":"He","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jbc.2025.110595_bib53","doi-asserted-by":"crossref","first-page":"37681","DOI":"10.1074\/jbc.M301406200","article-title":"Rapid tau aggregation and delayed hippocampal neuronal death induced by persistent thrombin signaling","volume":"278","author":"Suo","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib54","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312110120","article-title":"How a natural antibiotic uses oxidative stress to kill oxidant-resistant bacteria","volume":"120","author":"Gupta","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110595_bib55","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1212\/WNL.92.15_supplement.S4.001","article-title":"A first in human study of PBT434, a novel small molecule inhibitor of \u03b1-synuclein aggregation","volume":"92","author":"Stamler","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jbc.2025.110595_bib56","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.3390\/molecules26175301","article-title":"Short overview of some assays for the measurement of antioxidant activity of natural products and their relevance in dermatology","volume":"26","author":"Jaganjac","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2025.110595_bib57","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1021\/jf803537k","article-title":"Antioxidant assays for plant and food components","volume":"57","author":"Moon","year":"2009","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/fft2.10","article-title":"Guidelines for antioxidant assays for food components","volume":"1","author":"Xiao","year":"2020","journal-title":"Food Front."},{"key":"10.1016\/j.jbc.2025.110595_bib59","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1021\/jf0502698","article-title":"Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements","volume":"53","author":"Prior","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib60","doi-asserted-by":"crossref","first-page":"6049","DOI":"10.1016\/S0021-9258(18)63504-5","article-title":"Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)","volume":"244","author":"McCord","year":"1969","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/ijch.198300063","article-title":"Concerning the radical character of superoxide. The H-O bond energy of HO--2","volume":"23","author":"Liebman","year":"1983","journal-title":"Isr. J. Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib62","first-page":"280","article-title":"Ferric chelate enhances azo dye decolourisation by crude horseradish peroxidase","volume":"4","author":"Ambatkara","year":"2014","journal-title":"Universal J. Environ. Res. Technol."},{"key":"10.1016\/j.jbc.2025.110595_bib63","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1039\/B612672C","article-title":"Highly stable electrochemical oxidation of phenolic compounds at carbon ionic liquid electrode","volume":"132","author":"Safavi","year":"2007","journal-title":"Analyst"},{"key":"10.1016\/j.jbc.2025.110595_bib64","doi-asserted-by":"crossref","first-page":"18143","DOI":"10.1073\/pnas.0910065106","article-title":"The electrochemical approach to concerted proton--electron transfers in the oxidation of phenols in water","volume":"106","author":"Costentin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110595_bib65","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1590\/S0103-50532008000500029","article-title":"Electrochemistry of deferiprone as an orally active iron chelator and HIV-1 replication inhibitor and its determination","volume":"19","author":"Yadegari","year":"2008","journal-title":"J. Brazil Chem. Soc."},{"key":"10.1016\/j.jbc.2025.110595_bib66","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ab.2007.10.030","article-title":"Electrocatalytic oxidation and determination of deferasirox and deferiprone on a nickel oxyhydroxide-modified electrode","volume":"373","author":"Hajjizadeh","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jbc.2025.110595_bib67","doi-asserted-by":"crossref","DOI":"10.1149\/2.0241905jes","article-title":"Practical aspects of cyclic voltammetry: how to estimate reduction potentials when irreversibility prevails","volume":"166","author":"Espinoza","year":"2019","journal-title":"J. Electrochem. Soc."},{"key":"10.1016\/j.jbc.2025.110595_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0013-4686(85)80051-7","article-title":"A cyclic voltammetric study of the aqueous electrochemistry of some quinones","volume":"30","author":"Bailey","year":"1985","journal-title":"Electrochim. Acta"},{"key":"10.1016\/j.jbc.2025.110595_bib69","doi-asserted-by":"crossref","first-page":"102005","DOI":"10.5796\/electrochemistry.22-66082","article-title":"Cyclic voltammetry Part 1: fundamentals","volume":"90","author":"Yamada","year":"2022","journal-title":"Electrochemistry"},{"key":"10.1016\/j.jbc.2025.110595_bib70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/acs.jchemed.7b00361","article-title":"A practical beginner's guide to cyclic voltammetry","volume":"95","author":"Elgrishi","year":"2018","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.jbc.2025.110595_bib71","first-page":"74","article-title":"Traveling through the square mechanism of the quinone reduction pathways. Influence of the proton donor addition on the reaction intermediaries in a non-aqueous solvent","volume":"44","author":"Aguilar-Martinez","year":"2000","journal-title":"J. Mexican Chem. Soc."},{"key":"10.1016\/j.jbc.2025.110595_bib72","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/elan.200804263","article-title":"Voltametric behavior of trolox in methanol and ethanol solutions","volume":"20","author":"Karbarz","year":"2008","journal-title":"Electroanalysis"},{"key":"10.1016\/j.jbc.2025.110595_bib73","doi-asserted-by":"crossref","first-page":"9515","DOI":"10.18632\/aging.103225","article-title":"Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson's disease through AKT\/mTOR pathway","volume":"12","author":"Shi","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jbc.2025.110595_bib74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.jbc.2025.110595_bib75","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","article-title":"PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jbc.2025.110595_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1474-9726.2006.00196.x","article-title":"Radioiodinated clioquinol as a biomarker for \u03b2-amyloid: Zn2+ complexes in Alzheimer's disease","volume":"5","author":"Opazo","year":"2006","journal-title":"Aging Cell"},{"key":"10.1016\/j.jbc.2025.110595_bib77","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/DDDT.S49763","article-title":"8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications","volume":"7","author":"Prachayasittikul","year":"2013","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.jbc.2025.110595_bib78","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jbc.2025.110595_bib79","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ardp.201500453","article-title":"New hydroxyquinoline-based derivatives as potent modulators of amyloid-beta aggregations","volume":"349","author":"Fu","year":"2016","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.jbc.2025.110595_bib80","article-title":"Density functional theory study of the role of benzylic hydrogen atoms in the antioxidant properties of lignans","volume":"8","author":"Vo","year":"2018","journal-title":"Scientific Rep."},{"key":"10.1016\/j.jbc.2025.110595_bib81","first-page":"797","article-title":"Electrochemical detection of phenol in aqueous solutions","volume":"11","author":"Mathiyarasu","year":"2004","journal-title":"Ind. Jour. Chem. Tech."},{"key":"10.1016\/j.jbc.2025.110595_bib82","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/ars.2009.2876","article-title":"Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential","volume":"13","author":"Batini\u0107-Haberle","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jbc.2025.110595_bib83","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1021\/ic00031a041","article-title":"Spectroelectrochemistry of copper-zinc superoxide dismutase","volume":"31","author":"St. Clair","year":"1992","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jbc.2025.110595_bib84","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1021\/ed1007712","article-title":"Marcus theory: thermodynamics CAN control the kinetics of electron transfer reactions","volume":"89","author":"Silverstein","year":"2012","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.jbc.2025.110595_bib85","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2116\/analsci.21N030","article-title":"Redox reactions between ABTS\u2022(+) and dihydroxybenzenes as studied by cyclic voltammetry","volume":"38","author":"Matsumoto","year":"2022","journal-title":"Anal. Sci."},{"key":"10.1016\/j.jbc.2025.110595_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.elecom.2021.107190","article-title":"Electrochemical redox behavior of 2,2-diphenyl-1-picrylhydrazyl radical solubilized by \u03b2-cyclodextrin in water","volume":"134","author":"Nakanishi","year":"2022","journal-title":"Electrochem. Commun."},{"key":"10.1016\/j.jbc.2025.110595_bib87","first-page":"546","article-title":"Methods for determination of antioxidant capacity: a review","volume":"6","author":"Gupta","year":"2015","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.jbc.2025.110595_bib88","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.lfs.2008.12.008","article-title":"HT22 hippocampal neuronal cell line possesses functional cholinergic properties","volume":"84","author":"Liu","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.jbc.2025.110595_bib89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0165-0270(00)00179-5","article-title":"Rapid microplate assay for superoxide scavenging efficiency","volume":"97","author":"Quick","year":"2000","journal-title":"J. Neurosci. Methods"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825024469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925825024469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:05:08Z","timestamp":1778655908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925825024469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":88,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0021925825024469"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110595","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent antioxidant and mitochondrial-protective effects of ATH434, a moderate affinity iron chaperone","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110595","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110595"}}